Post-market Clinical Follow-up on the balanSys UNI Knee Prosthesis Implanted With a Spacer Block Surgical Technique
- Conditions
- Knee Arthropathy
- Registration Number
- NCT04598568
- Lead Sponsor
- Mathys Ltd Bettlach
- Brief Summary
The purpose of the study is the evaluation of the clinical and radiological long-term performance of the balanSys UNI fix in a multicenter routine clinical setting.
- Detailed Description
Prospective multicenter follow-up study which examines the short- to long-term post-market clinical data on the safety and performance of the balanSys UNI fix knee prosthesis.
In total at least 100 participants in 3 clinics are included in this multicenter study.
The primary endpoint of the study is the Knee Society Score (KSS) 2 years after surgery.
The following parameters will be collected during the regular clinical and radiological follow-up: Knee Society Score, Knee and Osteoarthritis Outcome Score (KOOS), radiographic evaluation and detection of adverse events.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 116
- Informed consent form (signed by participant and investigator)
- Primary implantation
- Age at inclusion: Between 18 and 90 years old
- Willing to participate in the follow-up
- Missing Informed consent form
- Known or suspected non-compliance (e.g. drug or alcohol abuse)
- Enrollment of the investigator, his/her family, employees and other dependent persons
- Patient younger than 18 years old
- Revision surgery
- Does have a known allergy to metal in medical devices
- Suffers from ACL rupture
- Pregnancy or in the breast feeding period
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knee Society Score 2 years The primary endpoint of the study is the Knee Society Score (KSS) 2 years after surgery
The Knee Society Score consists of an objective score (0-100 points) and a score for function (0-100 points).
A higher score means a better outcome.
- Secondary Outcome Measures
Name Time Method Radiographic evaluation of lucent lines 6-12 weeks - 10 years The second endpoint of interest is the incidence of lucent lines measured in millimeters by means of standard X-rays.
Adverse Events and Complications 6-12 weeks - 10 years Documentation of complication(s):
- Description of complication with the UKA
Documentation of component revision(s) (Adverse Events):
* Reason(s) for revision(s)
* Revised component(s)